Feasibility and long-term results of autologous PBSC transplantation in recurrent undifferentiated nasopharyngeal carcinoma

Head and Neck

Volumn 23, Issue 9, 2001, Pages 799-803

  Airoldi, Mario ^a   De Crescenzo, Alberto ^a   Pedani, Fulvia ^a   Marchionatti, Sara ^b   Gabriele, Anna Maria ^c   Succo, Giovanni ^a   Rosti, Giovanni ^a   Bumma, Cesare ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

Author keywords

Autologous peripheral blood stem cell transplantation; Chemotherapy; Metastases; Nasopharyngeal cancer; Recurrence

Indexed keywords

CARBOPLATIN; CD34 ANTIGEN; CISPLATIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE;

ADULT; ARTICLE; AUTOTRANSPLANTATION; BONE METASTASIS; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; NASOPHARYNX CARCINOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RECURRENT CANCER; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; TUMOR DIFFERENTIATION;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIRUBICIN; FEASIBILITY STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; TRANSPLANTATION, AUTOLOGOUS;

EID: 0034891569     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.1114     Document Type: Article

References (27)

1. An epidemiologic and clinical study of nasopharyngeal carcinoma
2. Undifferentiated nasopharyngeal cancer: Current diagnostic and therapeutic aspects
3. Megavoltage irradiation of epithelial tumors of the nasopharynx
4. Radiotherapeutic management of carcinoma of the nasopharynx
5. Distant metastases from head and neck cancer
6. Results of chemotherapy plus external re-irradiation in the treatment of locally advanced recurrences of nasopharyngeal carcinoma
7. Re-irradiation of recurrent nasopharyngeal carcinoma. Treatment techniques and results
8. Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil
9. BEC (bleomycinepirubicin-cisplatin) in metastatic/recurrent undifferentiated nasopharyngeal cancer
10. Combined chemotherapy for recurrent and metastatic nasopharyngeal carcinoma
11. Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx
12. Chemotherapy for nasopharyngeal carcinoma. A ten year experience
13. Cisplatin and fluorouracil in recurrent and/or disseminated nasopharyngeal carcinoma
14. A multicenter trial of Novantrone in advanced nasopharyngeal carcinoma in the Southeast Asia
15. Bone marrow biopsies in patients with undifferentiated carcinoma of the nasopharyngeal type
16. Cisplatin and Adriamycin combination chemotherapy in locoregional recurrent and metastatic nasopharyngeal carcinoma
17. Phase II trial of epirubicin and cisplatin in advanced undifferentiated nasopharyngeal carcinoma
18. Cisplatin and high dose epirubicin in non queratinizing epidermoid carcinoma of the nasopharynx
19. 5-Fluorouracil, mitomycin, epirubicin, cisplatin in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma. Preliminary activity/toxicity report
20. Epirubicin + G-CSF as peripheral blood progenitor cells mobilising agents in breast cancer patients
21. Phase II study of carboplatin and 5-FU combination in treatment of advanced nasopharyngeal carcinoma
22. High dose 5-fluorouracil plus cisplatinum in treatment of advanced nasopharyngeal carcinoma
23. Cisplatin and ifosfamide in advanced poorly differentiated carcinoma of the nasopharynx
24. Phase II trial of VP-16, bleomycin and cisplatin in patients with advanced nonsquamous cell head and neck neoplasms
25. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin and etoposide with autologous stem cell support
26. High dose ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ-cell tumors and metastatic trophoblastic disease in adults
27. Multicyclic dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood